Binod Aryal

Binod Aryal is currently the Director at Lilly Gene Therapy, focusing on translational research in cardiometabolic disorders. Previously, they served as a Senior Advisor in Preclinical R&D at Eli Lilly and Company and held the position of Scientist at Prevail Therapeutics, specializing in gene therapy for neurodegenerative disorders. Binod completed their PhD in Cell and Molecular Biology at New York University, where they focused on cardiovascular diseases and lipid disorders, following their undergraduate degree in Biotechnology from Saint Peter's College. They have also contributed to research at Yale University and Washington University School of Medicine.